Enrolling Clinical Research Studies

Adults Aged 60 Years And Older with a History of Urinary Tract In

Celiac Disease on a Gluten-Free Diet

Contraceptive Study

Evaluate the Safety and Efficacy of ABBV-154 in Subjects with Mod

Hot Flashes study

Influenza modRNA Vaccine

Tampon Applicator

Treatment of Active Celiac Disease in Subjects Attempting a Glute

TREATMENT OF ACUTE UNCOMPLICATED INFLUENZA-LIKE ILLNESS (FLU)

Uterine Fibroids or Endometriosis women who are at Risk for Pregn

Future Studies
Upcoming Studies for Men & Women

Upcoming Studies for Men & Women

Click to add your name to the waiting list for upcoming studies. We will alert you when we begin a new study. Please provide your email address if possible.

*PLEASE DO NOT CALL THE STUDY CENTER UNLESS YOU ARE CONTACTED FIRST*

» Study Details | Apply for the Study

Gastroenterology
 Moderately to Severely Active Crohn's Disease

Moderately to Severely Active Crohn's Disease

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of ABBV-154 in Subjects with Moderately to Severely Active Crohn's Disease (CD)

» Study Details | Apply for the Study

TAK-062-2001 Treatment of Active Celiac Disease in Subjects Attempting a Gl

TAK-062-2001 Treatment of Active Celiac Disease in Subjects Attempting a Gl

Participants are needed for the ILLUMINATE-062 Study, which is looking at the safety and effectiveness of an investigational medication designed to break down gluten in the stomach compared with placebo in those with celiac disease who are on a gluten-free diet. The study will evaluate how well the investigational medication reduces celiac-related symptoms and intestinal damage due to gluten exposure.   Participants who have been diagnosed with celiac, which was confirmed by a biopsy, and have been on a gluten-free diet for at least 12 months are needed. Study-related care is provided at no cost, and a travel stipend may be provided.

» Study Details | Apply for the Study

Prevention of Gluten-Specific T Cell Activation in Subjects with Celiac Dis

Prevention of Gluten-Specific T Cell Activation in Subjects with Celiac Dis

The ILLUMINATE-101 clinical research study is evaluating the safety and effectiveness of an investigational medication designed to reduce or eliminate the negative immune response to gluten in adults with celiac disease and participants are needed.

» Study Details | Apply for the Study

Women’s Health
Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safe

Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safe

A Phase 3, Multicenter, Open-Label, Single Arm Study of MR-100A-01 in Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safety

» Study Details | Apply for the Study

Combination Therapy in Women with Uterine Fibroids or Endometriosis who are

Combination Therapy in Women with Uterine Fibroids or Endometriosis who are

Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women with Uterine Fibroids or Endometriosis who are at Risk for Pregnancy

» Study Details | Apply for the Study

Moderate to Severe Vasomotor Symptoms in Postmenopausal Women

Moderate to Severe Vasomotor Symptoms in Postmenopausal Women

A Randomized Double-blind Placebo Controlled Phase 3 Trial to evaluate the Efficacy and Safety of Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women

» Study Details | Apply for the Study

 

An Open-Label Clinical Validation Study of an Applicator Tampon

An Open-Label Clinical Validation Study of an Applicator Tampon

» Study Details | Apply for the Study

ID
 

TREATMENT OF ACUTE UNCOMPLICATED INFLUENZA-LIKE ILLNESS

A PHASE 2B DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF THE EFFICACY AND SAFETY OF NORKETOTIFEN IN THE TREATMENT OF ACUTE UNCOMPLICATED INFLUENZA-LIKE ILLNESS (ILI)

» Study Details | Apply for the Study

STUDY TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF

STUDY TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF

STUDY TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A MODIFIED RNA VACCINE AGAINST INFLUENZA COMPARED TO LICENSED INACTIVATED INFLUENZA VACCINE IN HEALTHY ADULTS 18 YEARS OF AGE OR OLDER

» Study Details | Apply for the Study

History of Urinary Tract Infection in the Past 2 Years

History of Urinary Tract Infection in the Past 2 Years

Prevention of Invasive Extraintestinal Pathogenic Escherichia coli Disease in Adults Aged 60 Years And Older with a History of Urinary Tract Infection in the Past 2 Years

» Study Details | Apply for the Study

Powered By RealTime-CTMS Clinical Trial Management System